# A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia

> **NCT00380081** · PHASE3 · COMPLETED · sponsor: **Transcept Pharmaceuticals** · enrollment: 82 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** zolpidem tartrate sublingual tablet 3.5mg
- **DRUG:** zolpidem tartrate sublingual tablet 1.75mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00380081
- **Lead sponsor:** Transcept Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2012-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380081, "A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT00380081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*